Recommendation of the President – Filsuvez (birch bark extract)

On 3 December 2024, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 131/2024 on the appraisal Filsuvez (birch bark extract) in a prescription pharmacy for the indication: treatment of partial thickness wounds associated with the dystrophic form of bullous epidermal separation (DEB) and the borderline form of bullous epidermal separation (JEB) in patients 6 months of age and older

Publication in Public Information Bulletin (BIP) >>